Recombinant CD274 (Garivulimab Biosimilar) antibody

Catalog No. ABIN7597713

This Humanized Chimeric antibody specifically detects CD274 (Garivulimab Biosimilar) . It exhibits reactivity toward Human.

Quick Overview for Recombinant CD274 (Garivulimab Biosimilar) antibody (ABIN7597713)

Target: CD274 (Garivulimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This CD274 (Garivulimab Biosimilar) antibody is un-conjugated

Grade: Research Grade

Product Details anti-CD274 (Garivulimab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Garivulimab Biosimilar Antibody

Specificity: B7-H1, Programmed cell death 1 ligand 1, PDCD1 ligand 1, PDCD1L1, B7 homolog 1, PDCD1LG1, PDL1, hPD-L1, Programmed death ligand 1, B7H1, PD-L1, CD274

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for CD274 (Garivulimab Biosimilar)

Target: CD274 (Garivulimab Biosimilar)

Alternative Name: Garivulimab Biosimilar

Target Type: Biosimilar

Background: B7-H1, Programmed cell death 1 ligand 1, PDCD1 ligand 1, PDCD1L1, B7 homolog 1, PDCD1LG1, PDL1, hPD-L1, Programmed death ligand 1, B7H1, PD-L1, CD274

UniProt: Q9NZQ7

CAS-No: 2342597-81-1